Hematologic Tests
0
Pipeline Programs
2
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AbbottCapillary blood draw
AbbottBlood draw
EssenlixiMOST X-1 Hematology Analyzer
Clinical Trials (3)
Total enrollment: 910 patients across 3 trials
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
Start: Sep 2025Est. completion: Dec 2026425 patients
N/ARecruiting
Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Specimens
Start: Sep 2025Est. completion: Dec 2026425 patients
N/ARecruiting
Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study
Start: Oct 2020Est. completion: Jan 202160 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 910 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.